Target intelligence / Profile preview

Demodex mite

Molecular classification
Other (Ectoparasite, Arachnid, Mite)
01

Overview

Demodex mites are microscopic arachnids that live in or near the hair follicles and sebaceous glands of mammals, including humans. The two main species found on humans are *Demodex folliculorum* and *Demodex brevis*. These mites are typically harmless commensals but can become pathogenic when they multiply excessively—often due to immunosuppression—causing a condition known as demodicosis. Symptoms include itching, redness, acne-like blemishes, rough skin texture, and sometimes eye irritation if the eyelids are involved. Most people carry these mites without any symptoms throughout their lives. The life cycle of Demodex is completed entirely on the host; adults mate at night near hair follicles before returning to lay eggs inside them. Transmission occurs primarily through close contact with other hosts. While generally not considered a direct therapeutic target like a receptor or enzyme molecule would be in drug development contexts, treatments for symptomatic infestations involve topical acaricidal agents that kill the mites. Because "Demodex mite" refers to an entire organism rather than a molecular target such as a receptor or enzyme—and because it encompasses multiple species—it is not considered a canonical therapeutic target molecule/receptor for structured pharmacological databases.[2][3][4][5]

Other names
DemodexFace miteFollicle miteDemodex folliculorum (species)Demodex brevis (species)Demodex canis (in dogs)
02

Mechanism of action

Killing mites by disrupting their nervous system or metabolism via topical acaricides[5]

03

Biological functions

Parasitism/commensalism on mammalian skinFeeding on dead skin cells, oils, and hormones in hair follicles[6]Nocturnal activity synchronized with host circadian rhythm[1]
04

Disease associations

Infection (demodicosis/demodicidosis)[5][6]Inflammation of the skin and eyes[5][6]Rosacea-like symptoms[6]
05

Interacting drugs

Acaricides (general class; e.g., topical creams or washes containing acaricides)[5]

Beyond the preview

Go deeper on Demodex mite.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Demodex mite.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call